Esther Vicente

Esther Vicente

UNVERIFIED PROFILE

Are you Esther Vicente?   Register this Author

Register author
Esther Vicente

Esther Vicente

Publications by authors named "Esther Vicente"

Are you Esther Vicente?   Register this Author

45Publications

1720Reads

34Profile Views

Positron emission tomography/computed tomography in relapsing polychondritis.

Rheumatology (Oxford) 2020 Jan;59(1):7-8

Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez400DOI Listing
January 2020

Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region.

Orphanet J Rare Dis 2019 12 2;14(1):276. Epub 2019 Dec 2.

Department of Neurology, Complejo Hospitalario de Navarra, IdiSNA (Navarre Institute for Health Research), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-019-1227-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889463PMC
December 2019

Accounting for respiratory motion in small serial structures during radiotherapy planning: proof of concept in virtual bronchoscopy-guided lung functional avoidance radiotherapy.

Phys Med Biol 2019 11 21;64(22):225011. Epub 2019 Nov 21.

Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, United States of America. Author to whom correspondence should be addressed.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/ab52a1DOI Listing
November 2019

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Authors:
Lorenzo Cavagna Ernesto Trallero-Araguás Federica Meloni Ilaria Cavazzana Jorge Rojas-Serrano Eugen Feist Giovanni Zanframundo Valentina Morandi Alain Meyer Jose Antonio Pereira da Silva Carlo Jorge Matos Costa Oyvind Molberg Helena Andersson Veronica Codullo Marta Mosca Simone Barsotti Rossella Neri Carlo Scirè Marcello Govoni Federica Furini Francisco Javier Lopez-Longo Julia Martinez-Barrio Udo Schneider Hanns-Martin Lorenz Andrea Doria Anna Ghirardello Norberto Ortego-Centeno Marco Confalonieri Paola Tomietto Nicolò Pipitone Ana Belen Rodriguez Cambron María Ángeles Blázquez Cañamero Reinhard Edmund Voll Sarah Wendel Salvatore Scarpato Francois Maurier Massimiliano Limonta Paolo Colombelli Margherita Giannini Bernard Geny Eugenio Arrigoni Elena Bravi Paola Migliorini Alessandro Mathieu Matteo Piga Ulrich Drott Christiane Delbrueck Jutta Bauhammer Giovanni Cagnotto Carlo Vancheri Gianluca Sambataro Ellen De Langhe Pier Paolo Sainaghi Cristina Monti Francesca Gigli Berzolari Mariaeva Romano Francesco Bonella Christof Specker Andreas Schwarting Ignacio Villa Blanco Carlo Selmi Angela Ceribelli Laura Nuno Antonio Mera-Varela Nair Perez Gomez Enrico Fusaro Simone Parisi Luigi Sinigaglia Nicoletta Del Papa Maurizio Benucci Marco Amedeo Cimmino Valeria Riccieri Fabrizio Conti Gian Domenico Sebastiani Annamaria Iuliano Giacomo Emmi Daniele Cammelli Marco Sebastiani Andreina Manfredi Javier Bachiller-Corral Walter Alberto Sifuentes Giraldo Giuseppe Paolazzi Lesley Ann Saketkoo Roberto Giorgi Fausto Salaffi Jose Cifrian Roberto Caporali Francesco Locatelli Enrico Marchioni Alberto Pesci Giulia Dei Maria Rosa Pozzi Lomater Claudia Jorg Distler Johannes Knitza George Schett Florenzo Iannone Marco Fornaro Franco Franceschini Luca Quartuccio Roberto Gerli Elena Bartoloni Silvia Bellando Randone Giuseppe Zampogna Montserrat I Gonzalez Perez Mayra Mejia Esther Vicente Konstantinos Triantafyllias Raquel Lopez-Mejias Marco Matucci-Cerinic Albert Selva-O'Callaghan Santos Castañeda Carlomaurizio Montecucco Miguel Angel Gonzalez-Gay

J Clin Med 2019 Nov 18;8(11). Epub 2019 Nov 18.

Department of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria Santander, 39008 Santander, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8112013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912490PMC
November 2019

Association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis-related calcinosis.

Rheumatology (Oxford) 2019 07;58(7):1299-1301

Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, PTS Granada, Granada, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez015DOI Listing
July 2019

Treatment of polymyalgia rheumatica.

Biochem Pharmacol 2019 07 20;165:221-229. Epub 2019 Mar 20.

Division of Rheumatology and Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; University of Cantabria, Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00062952193011
Publisher Site
http://dx.doi.org/10.1016/j.bcp.2019.03.027DOI Listing
July 2019

Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.

J Rheumatol 2019 03 15;46(3):279-284. Epub 2018 Nov 15.

From the Rheumatology Unit, Azienda Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy; ACURA Rheumatology Center, Bad Kreuznach, Germany; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDiVAL, University of Cantabria, Santander, Spain; Rheumatology Division, University Hospital of Frankfurt, Frankfurt, Germany; Interstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico City, Mexico; Servicio de Reumatología, Hospital Universitario La Paz, Madrid, Spain; Interdisciplinary Department of Medicine (DIM), Rheumatology Unit, University of Bari, Bari, Italy; Rheumatology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria (IIS) Princesa, Madrid; Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Universidad Autonoma de Barcelona, on behalf of the GEAS group, Barcelona, Spain; Department of Experimental and Clinical Medicine, and Department of Medical and Surgical Critical Care, Section of Dermatology, University of Florence, Florence; Unità Operativa Complessa (UOC) Reumatologia, Ospedale San Camillo-Forlanini, Rome; ACURA Centre for Rheumatic Diseases, Baden-Baden, Germany; Rheumatology Department, Città Della Salute e della Scienza, Torino; Division of Rheumatology, University and Institute for Research and Health Care (IRCCS) Policlinico S. Matteo Foundation, Pavia, Italy; Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Dermatology Clinic, University Hospital of Trieste; Department of Pneumology and Respiratory Intermediate Care Unit, University Hospital of Cattinara, Trieste; Rheumatology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Trieste, Trieste, Italy; Medizinische Klinik A, Klinikum der Stadt, Ludwigshafen, Germany; Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, San Martino Polyclinic Hospital IRCCS Genoa, Genoa, Italy; Interstitial and Rare Lung Disease Unit, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany; UOC Reumatologia, Azienda Ospedaliero Universitaria S. Anna, University of Ferrara, Italy; Department for Rheumatology and Clinical Immunology, St. Josef Krankenhaus, University Clinic, Essen, Germany; Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; Department of Internal Medicine, Rheumatology and Clinical Immunology, University Hospital Johannes-Gutenberg, Mainz, Germany; University of Ghent, Ghent University Hospital, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180355
Publisher Site
http://dx.doi.org/10.3899/jrheum.180355DOI Listing
March 2019

[Implementing a population-based rare diseases registry in Spain: the Navarre´s experience].

Rev Esp Salud Publica 2018 Nov 19;92. Epub 2018 Nov 19.

Sección del Observatorio de la Salud Comunitaria. Servicio de Promoción de la Salud Comunitaria. Instituto de Salud Pública y Laboral de Navarra. Pamplona. España.

View Article

Download full-text PDF

Source
November 2018

Simplifying volumes-of-interest (VOIs) definition in quantitative SPECT: Beyond manual definition of 3D whole-organ VOIs.

Med Phys 2017 May 28;44(5):1707-1717. Epub 2017 Mar 28.

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.12164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462436PMC
May 2017

Reply.

Med Clin (Barc) 2017 02 27;148(3):e15-e16. Epub 2016 Dec 27.

Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, España; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Universidad de Cantabria, IDIVAL, Santander, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.11.009DOI Listing
February 2017

18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.

Clin Nucl Med 2017 Jan;42(1):e16-e21

From the *Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD; and †Department of Radiology, and ‡Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360463PMC
January 2017

[Adult-onset Still's disease].

Med Clin (Barc) 2016 09 18;147(5):217-222. Epub 2016 May 18.

Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, España; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Universidad de Cantabria, Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.03.034DOI Listing
September 2016

Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases: comment on 'Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative' by Baillet et al.

Ann Rheum Dis 2016 08 25;75(8):e55. Epub 2016 May 25.

Rheumatology Division, Department of Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209836DOI Listing
August 2016

Repeatability of Radiotracer Uptake in Normal Abdominal Organs with ¹¹¹In-Pentetreotide Quantitative SPECT/CT.

J Nucl Med 2015 Jul 14;56(7):985-8. Epub 2015 May 14.

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.155358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493864PMC
July 2015

Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis.

Infect Disord Drug Targets 2011 Apr;11(2):196-204

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, University of Navarra, C/ Irunlarrea s/n, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152611795589735DOI Listing
April 2011

Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.

Bioorg Med Chem Lett 2010 Aug 25;20(16):4831-5. Epub 2010 Jun 25.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, University of Navarra, C/Irunlarrea s/n, 31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.06.101DOI Listing
August 2010

Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis.

J Rheumatol 2010 Jul 15;37(7):1502-4. Epub 2010 May 15.

Instituto de Parasitología y Biomedicina López Neyra, ConsejoSuperior de Investigaciones Cientificas, San Cecílio, Granada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100016DOI Listing
July 2010

Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.

Chem Biol Drug Des 2010 Jul 11;76(1):59-69. Epub 2010 May 11.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, 31008 Pamplona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1747-0285.2010.00980.xDOI Listing
July 2010

QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.

J Mol Graph Model 2009 Aug 31;28(1):28-36. Epub 2009 Mar 31.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, C/Irunlarrea s/n, 31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmgm.2009.03.004DOI Listing
August 2009

Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.

Bioorg Med Chem 2009 Jan 5;17(1):385-9. Epub 2008 Nov 5.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, C/Irunlarrea s/n, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2008.10.086DOI Listing
January 2009

Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives.

Mem Inst Oswaldo Cruz 2008 Dec;103(8):778-80

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, University of Navarra, Campus Universitario, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0074-02762008000800006DOI Listing
December 2008

Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents.

Eur J Med Chem 2008 Sep 7;43(9):1903-10. Epub 2007 Dec 7.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, C/Irunlarrea s/n, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2007.11.024DOI Listing
September 2008

In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.

J Antimicrob Chemother 2008 Sep 23;62(3):547-54. Epub 2008 May 23.

Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), Universidad de Navarra, C/Irunlarrea s/n, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/
Publisher Site
http://dx.doi.org/10.1093/jac/dkn214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2574959PMC
September 2008

Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.

Antimicrob Agents Chemother 2008 Sep 14;52(9):3321-6. Epub 2008 Jul 14.

Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, Universidad de Navarra, Irunlarrea, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00379-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533452PMC
September 2008

Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives.

Exp Parasitol 2008 Jan 2;118(1):25-31. Epub 2007 Jun 2.

Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, University of Navarra, Campus Universitario, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exppara.2007.05.009DOI Listing
January 2008

Synthesis and antiplasmodial activity of 3-furyl and 3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.

Molecules 2008 Jan 17;13(1):69-77. Epub 2008 Jan 17.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245472PMC
http://dx.doi.org/10.3390/molecules13010069DOI Listing
January 2008

Unexpected reduction of ethyl 3-phenylquinoxaline-2- carboxylate 1,4-di-N-oxide derivatives by amines.

Molecules 2008 Jan 17;13(1):78-85. Epub 2008 Jan 17.

Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245414PMC
http://dx.doi.org/10.3390/molecules13010078DOI Listing
January 2008

Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivatives.

Molecules 2008 Jan 18;13(1):86-95. Epub 2008 Jan 18.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245059PMC
http://dx.doi.org/10.3390/molecules13010086DOI Listing
January 2008

Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.

Bioorg Med Chem Lett 2007 Dec 5;17(23):6439-43. Epub 2007 Oct 5.

Unidad de Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), Universidad de Navarra, c/Irunlarrea s/n, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.10.002DOI Listing
December 2007

Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.

J Med Chem 2007 Nov 2;50(22):5485-92. Epub 2007 Oct 2.

Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), University of Navarra, c/Irunlarrea s/n, 31080 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm0703993DOI Listing
November 2007

[Relapsing polychondritis associated with a lymphoplasmocytic lymphoma and erythema nodosum].

Reumatol Clin 2007 Jan 13;3(1):45-7. Epub 2008 Nov 13.

Servicio de Reumatología. Hospital Universitario de la Princesa. Madrid. España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1699-258X(07)73598-2DOI Listing
January 2007